FDA.reportPublic FDA data

insulin, human isophane / insulin regular 70/30 Injectable Suspension

RxCUI
311048
RxNorm name
insulin, human isophane / insulin regular 70/30 Injectable Suspension
Display name
insulin, human isophane / insulin regular 70/30 Injectable Suspension
Full name
insulin, human isophane / insulin regular 70/30 Injectable Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
019991Novolin 70/30insulin isophane human and insulin human351(a)OTC2026-07-01
019717Humulin 70/30insulin isophane human and insulin human351(a)OTC2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Humulin 70/30INSULIN HUMANEli Lilly and Companye245e0c5-b2d6-418b-baa4-1c33242928852025-12-04Warnings, Adverse reactionsExact identifier
rxcui: 311048
Novolin 70/30HUMAN INSULINA-S Medication Solutionse825d7e9-467c-4f50-a6d6-f2602449c1de2023-02-06Warnings, Adverse reactionsExact identifier
rxcui: 311048
Novolin 70/30HUMAN INSULINNovo Nordisk508a2763-3cb7-4be5-9e53-544e84cd9b1f2022-11-23Warnings, Adverse reactionsExact identifier
rxcui: 311048

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e245e0c5-b2d6-418b-baa4-1c3324292885insulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]348These highlights do not include all the information needed to use HUMULIN 70/30 safely and effectively. See full prescribing information for HUMULIN 70/30. HUMULIN 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 198920241210
508a2763-3cb7-4be5-9e53-544e84cd9b1finsulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]318These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN ® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120221123
e825d7e9-467c-4f50-a6d6-f2602449c1deinsulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]314These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN ® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120230206
7f6328dc-2270-4cbd-bcb2-fb0f32a1e872insulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]310These highlights do not include all the information needed to use HUMULIN 70/30 safely and effectively. See full prescribing information for HUMULIN 70/30. HUMULIN ® 70/30 (70% human insulin isophane suspension and 30% human insulin injection [rDNA origin]) injectable suspension, for subcutaneous use Initial U.S. Approval: 198920171012
0cc57309-01ef-4a02-8d27-b981c768135ainsulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]32Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ®20130830
8c7038f4-60d4-4604-814d-74921cdc1ad8insulin, human isophane / insulin regular 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [SCD] · insulin, human mixed 70/30 100 UNT/ML Injectable Suspension [SY]32Novolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)20120111